Local Organizing Committee

  

Local Organizing Committee  

Co-chair:

Eduardo Tolosa, MD

Co-chair:

Miquel Vila, MD, PhD  

 

Ernest Arenas, PhD

 

Ana Camara, RN

  Isable Fariñas, PhD
 

Jaime Kulisevski, MD

Maria Jose Marti, MD

Laura Morer

Rose Roige


Eduardo Tolosa, MD

Eduardo Tolosa, MD obtained his MD degree from the University of Barcelona and received his neurological training at the University of Minnesota in Minneapolis. He is a founding member and past President of the Movement Disorder Society. He is also past President of the Spanish and of the European Neurological Society.  He is the recipient of the  American Academy of Neurology  2014 Movement Disorders Research Award. Prof. Tolosa is currently Vice Director of Research of the Centro de Investigacion en Red de Enfermedades Neurodegenerativas at the Instituto de Salud Carlos III in Spain,  Emeritus Professor at the University of Barcelona and Neurology consultant Hospital Clinic Universitary.

Professor Tolosa’s research interests are in movement disorders. He was involved in pioneering studies defining the mechanisms underlying levodopa-related motor fluctuations and  the role of DAT SPECT in the diagnosis of Parkinson disease  and his team has been among the first in Europe to evaluate the efficacy of novel therapeutic strategies for Parkinson’s disease, such as subthalamic nucleus stimulation, subcutaneous dopamine agonist infusions and intraduodenal infusions of levodopa. Areas of current research include assessment of non-motor  symptoms in asymptomatic  carriers of Parkinson-associated  genetic mutations and the study of diagnostic  biomarkers in premotor  Parkinson disease.

Miquel Vila, MD, PhD

Miquel Vila, MD, PhD obtained his MD degree from the University of Barcelona and a PhD in Neuroscience from the University of Paris. He received his PhD training at the Salpêtrière Hospital in Paris under the supervision of Dr. Etienne C. Hirsch, devoted to the study of the functional consequences of dopaminergic neurodegeneration on the functioning of the basal ganglia. He then worked as a postdoctoral researcher at the laboratory of Dr. Serge Przedborski at Columbia University in New York, where he subsequently obtained a position as an Assistant Professor of Neurology, focusing on the molecular mechanisms of neuronal death in Parkinson's disease. Currently, he is a Professor at the Catalan Institution for Research and Advanced Studies (ICREA) and leads the Neurodegenerative Diseases Research Group at the Vall d’Hebron Research Institute in Barcelona.

Dr. Vila’s work has been devoted to the functional changes in the circuitry of the basal ganglia and the molecular mechanisms underlying neuronal dysfunction and degeneration in Parkinson's disease using experimental animal models in rodents and non-human primates, with special emphasis on the role of mitochondria dysfunction, activation of programmed cell death pathways, alpha-synuclein aggregation/propagation, neuroinflammation and age-dependent neuromelanin accumulation.

Ernest Arenas, PhD 

Ana Camara, RN 

Isable Fariñas, PhD

Jaime Kulisevski, MD 

Miquel Vila, MD, PhD

Maria Jose Marti, MD is an Associate Professor of Neurology, Consultant in Neurology and Director of the Parkinson’s disease and Movement Disorders Unit of the Service of Neurology. Hospital Clinic i Universitari of Barcelona, and Director of the “Neurodegenerative disease: Clinical and Experimental Research Group” Institut d’Investigacions Biomediques Agusti Pi I Sunyer (IDIBAPS).

She is also the coordinator of the Center of Rare Disease with Movement Disorders, Hospital Clinic-Hospital Sant Joan de Deu, Barcelona and coordinator of the Agrupacion Sanitaria Hospital Clinic-Sant Joan de Deu European Reference Network for Rare Neurological Diseases (ERN-RND).

Dr Marti is Co-Principal Investigator of the Spanish Biomedical Network Research Centre for Neurodegenerative Diseases (CIBERNED-Instituto de Salud Carlos III). Her research activities have centered mainly on dystonia and clinical, radiological
and biochemical markers of Parkinson’s disease and atypical parkinsonism. She is the author of more than 200 papers in peer-reviewed scientific journals and reviewer in several international medical journals.

Laura Morer

Rose Roige 

BACK TO TOP

Powered by YourMembership  ::  Legal